Your browser doesn't support javascript.
loading
Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study.
Hajiyev, Kamran; Henkes, Hans; Khanafer, Ali; Bücke, Philipp; Hennersdorf, Florian; Bäzner, Hansjörg; von Gottberg, Philipp.
Afiliação
  • Hajiyev K; Neuroradiologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
  • Henkes H; Neuroradiologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
  • Khanafer A; Medizinische Fakultät, Universität Duisburg-Essen, Essen, Germany.
  • Bücke P; Neuroradiologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
  • Hennersdorf F; Universitätsklinik für Neurologie, Bern University Hospital, Inselspital, Bern, Switzerland.
  • Bäzner H; Abteilung Diagnostische und Interventionelle Neuroradiologie, Radiologische Universitätsklinik Tübingen, Tübingen, Germany.
  • von Gottberg P; Neurologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
Cardiovasc Intervent Radiol ; 47(3): 291-298, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38326576
ABSTRACT

PURPOSE:

Endovascular and surgical treatments of stenosis of the extracranial internal carotid artery (ICA) are common procedures, yet both introduce a risk of restenosis due to endothelial hyperplasia. Drug-coated balloons (DCBs) are designed to decrease neointimal hyperplasia, however rarely used in the neurovascular setting. This study retrospectively analyzes mid-term results of DCB-treated in-stent restenosis (ISR) of the ICA. MATERIALS AND

METHODS:

The medical history, comorbidities, and periprocedural data of patients receiving DCB treatment for > 50% ISR of the ICA after carotid artery stenting were analyzed. Follow-up after DCB treatment was performed with Doppler ultrasound. Suspicious cases were checked with CT- or MR-angiography and-if there was agreement between the modalities-validated with digital subtraction angiography. Potential risk factors for restenosis and differences in outcomes after PTA with three types of DCB balloons were evaluated.

RESULTS:

DCB treatment was performed in 109 cases, 0.9% of which involved in-hospital major stroke; no minor strokes occurred. A total of 17 patients (15.6%) had recurrent ISR after DCB treatment, after a mean time of 30.2 months (7-85 months). Tobacco use was significantly associated with a higher incidence of recurrent ISR.

CONCLUSION:

DCB angioplasty for ISR is an effective treatment that may delay and decrease restenosis. Treating comorbidities and adopting lifestyle changes may additionally help prevent ISR.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose das Carótidas / Reestenose Coronária Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose das Carótidas / Reestenose Coronária Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article